Most importantly, the expression of stem cell markers such as Nanog, Sox2 and Oct4 is closely associated with HNSCC patient’s prognosis, pathological stages, cancer recurrence and therapy resistance [55,56]. This evidence concerns the gene SOX2 and head and neck squamous cell carcinoma.